Submitted by Anonymous (not verified) on 18 August 2026 - 13:47
Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation: 19/09/2024, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation: 19/09/2024, Revision: 5, Status: Authorised